Wide complex tachycardia resident survival guide: Difference between revisions

Jump to navigation Jump to search
Line 55: Line 55:
{{familytree | | | | E01 | | E02 | | E03 | | E04 | | E05 | | E06 | E01='''[[Ventricular tachycardia]] or uncertain rhythm?'''|E02='''[[SVT]] with aberrancy?'''|E03='''[[Afib]] with aberrancy?'''|E04='''Pre-excited [[Afib]] ([[Afib]] + [[WPW]])?'''|E05='''Recurrent polymorphic [[VT]]?'''|E06='''[[Torsade de pointes]]?'''}}
{{familytree | | | | E01 | | E02 | | E03 | | E04 | | E05 | | E06 | E01='''[[Ventricular tachycardia]] or uncertain rhythm?'''|E02='''[[SVT]] with aberrancy?'''|E03='''[[Afib]] with aberrancy?'''|E04='''Pre-excited [[Afib]] ([[Afib]] + [[WPW]])?'''|E05='''Recurrent polymorphic [[VT]]?'''|E06='''[[Torsade de pointes]]?'''}}
{{familytree | | | | |!| | | |!| | | |!| | | |!| | | |!| | | |!| | }}
{{familytree | | | | |!| | | |!| | | |!| | | |!| | | |!| | | |!| | }}
{{familytree | | | | F01 | | F02 | | F03 | | F04 | | F05 | | F06 | F01=- Give [[amiodarone]] 150 mg IV over 10 min<br><br>- Repeat [[amiodarone]] as needed for a maximal dose of 2.2g/24h<br><br>- Prepare for elective synchronized [[cardioversion]]| F02=- Give [[adenosine]] 6 mg rapid IV push<br><br>- If no [[conversion]] give 12 mg IV push<br><br>- May repeat 12 mg dose once| F03=- Consider expert consultation<br><br>- Control rate e.g [[diltiazem]] or [[beta blocker]]s<br>Use [[beta blocker]]s with caution in [[pulmonary disease]]s or [[CHF]]| F04= - Consider expert consultation<br><br>- Avoid AV nodal blocking agents<br>e.g [[adenosine]], [[digoxin]], [[diltiazem]] and [[verapamil]]<br><br>- Consider [[amiodarone]] 150 mg IV over 10 min| F05= Consider expert consultation| F06=Load with [[Magnesium]] 1-2 g over 5-60 min, then infusion}}
{{familytree | | | | F01 | | F02 | | F03 | | F04 | | F05 | | F06 | F01=Attempt vagal maneuvers <br>- Give [[amiodarone]] 150 mg IV over 10 min<br><br>- Repeat [[amiodarone]] as needed for a maximal dose of 2.2g/24h<br><br>- Prepare for elective synchronized [[cardioversion]]| F02=- Give [[adenosine]] 6 mg rapid IV push<br><br>- If no [[conversion]] give 12 mg IV push<br><br>- May repeat 12 mg dose once| F03=- Consider expert consultation<br><br>- Control rate e.g [[diltiazem]] or [[beta blocker]]s<br>Use [[beta blocker]]s with caution in [[pulmonary disease]]s or [[CHF]]| F04= - Consider expert consultation<br><br>- Avoid AV nodal blocking agents<br>e.g [[adenosine]], [[digoxin]], [[diltiazem]] and [[verapamil]]<br><br>- Consider [[amiodarone]] 150 mg IV over 10 min| F05= Consider expert consultation| F06=Load with [[Magnesium]] 1-2 g over 5-60 min, then infusion}}
{{familytree/end}}
{{familytree/end}}



Revision as of 01:19, 2 March 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]

Definition

Wide complex tachycardia is characterized by a heart rate more than 100 beats per minute associated with a QRS interval of more than 120 ms. When wide complex tachycardia is present, it is important to determine whether the tachycardia is of a supraventricular or a ventricular origin.[1]

Causes

Life Threatening Causes

Common Causes

Management

Diagnostic Approach

 
 
Characterize the symptoms:
❑ Asymptomatic PalpitationsDyspnea
Fatigue Chest discomfort Lightheadedness
Syncope

Characterize the timing of the symptoms:
❑ Onset
❑ Duration
❑ Frequency

 
 
 
 
 
 
 
 
 
 
 
Identify possible triggers:
InfectionCaffeineAlcohol
Nicotine ❑ Recreational drugsHypovolemia
Hyperthyroidism
 
 
 
 
 
 
 
 
 
 
 
❑ Examine the patient
 
 
 
 
 
 
 
 
 
 
 
❑ Order an EKG
 

Therapeutic Approach

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Wide complex tachycardia
QRS ≥ 120ms
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Do the following simultaneously:

- Assess and support ABC's as needed
- Give oxygen
- Monitor ECG, BP, oxymetry
- Identify and treat reversible causes
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Is the patient stable?

Unstable signs include:
- Chest pain
- Congestive heart failure
- Hypotension
- Loss of consciousness
- Seizures
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes
 
 
 
 
 
 
 
 
 
 
 
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Is the rhythm regular?
 
 
 
 
 
 
 
 
 
 
 
 
Immediate synchronized cardioversion

-Establish IV access
- Give IV sedation if the patient is conscious
- Consider expert consultation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Regular rhythm
 
 
 
 
 
 
 
 
 
Irregular rhythm
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ventricular tachycardia or uncertain rhythm?
 
SVT with aberrancy?
 
Afib with aberrancy?
 
Pre-excited Afib (Afib + WPW)?
 
Recurrent polymorphic VT?
 
Torsade de pointes?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Attempt vagal maneuvers
- Give amiodarone 150 mg IV over 10 min

- Repeat amiodarone as needed for a maximal dose of 2.2g/24h

- Prepare for elective synchronized cardioversion
 
- Give adenosine 6 mg rapid IV push

- If no conversion give 12 mg IV push

- May repeat 12 mg dose once
 
- Consider expert consultation

- Control rate e.g diltiazem or beta blockers
Use beta blockers with caution in pulmonary diseases or CHF
 
- Consider expert consultation

- Avoid AV nodal blocking agents
e.g adenosine, digoxin, diltiazem and verapamil

- Consider amiodarone 150 mg IV over 10 min
 
Consider expert consultation
 
Load with Magnesium 1-2 g over 5-60 min, then infusion

Algorithm based on the 2003 ACLS guidelines for the management of tachycardia.[1]

Do's

  • Refer the patient to an arrhythmia specialist in case the tachycardia causes syncope or dyspnea as well as the wide complex tachycardia is of unknown cause.[1]
  • Place an ambulatory 24 hour Holter when the tachycardia is frequent and transient.[1]

Dont's

References

  1. 1.0 1.1 1.2 1.3 Blomström-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ; et al. (2003). "ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society". J Am Coll Cardiol. 42 (8): 1493–531. PMID 14563598.

Template:WH Template:WS